GO:0090557 establishment of endothelial intestinal barrier: Barrier Formation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090557 describes the establishment of a selective barrier between intestinal endothelial cell layers that controls water and solute passage, maintaining distinct fluid and solute compartments.
• Intestinal endothelial barrier function is critical for gut homeostasis, immune surveillance, and prevention of systemic inflammation.
• Key molecular players include aryl hydrocarbon receptor (AHR) signaling in endothelial cells, which regulates intestinal homeostasis.
• Disruption of the endothelial intestinal barrier is implicated in inflammatory bowel disease (IBD), sepsis, and cancer metastasis.
• Advanced in vitro models, such as microfluidic on-chip systems and 3D multi-layered models, enable mechanistic studies of barrier establishment.
• CRISPR-based gene editing (knockout, knock-in, overexpression) is essential for dissecting gene function in endothelial barrier biology.
Description
The establishment of the endothelial intestinal barrier (GO:0090557) is a fundamental biological process that creates a selective interface between the bloodstream and the intestinal tissue. This barrier is formed by endothelial cells lining the intestinal microvasculature and is essential for controlling the passage of water, solutes, and immune cells, thereby maintaining tissue homeostasis and preventing systemic inflammation. The gut-liver axis, for instance, relies on intact endothelial barriers to regulate metabolic and immune crosstalk. Dysregulation of this barrier contributes to a range of pathologies, including inflammatory bowel disease, sepsis, and cancer metastasis. Understanding the molecular mechanisms that govern barrier establishment is therefore of significant clinical and research interest. Recent advances in microfluidic and 3D culture systems have provided powerful tools to model and interrogate this process in vitro. This article synthesizes current knowledge on the genes, signaling pathways, and experimental approaches relevant to GO:0090557, with a focus on CRISPR-based strategies for functional genomics.
establishment of endothelial intestinal barrier At A Glance
| GO ID | GO:0090557 |
|---|---|
| GO term | establishment of endothelial intestinal barrier |
| Ontology | biological_process |
| Synonym | None |
| Major function | Selective control of water and solute passage between endothelial cell layers in the intestine |
| Related processes | Gut-liver axis, immune cell trafficking, inflammatory responses |
| Key cell types | Intestinal microvascular endothelial cells, pericytes |
| Disease relevance | Inflammatory bowel disease, sepsis, cancer metastasis |
What Is GO:0090557?
GO:0090557, establishment of endothelial intestinal barrier, refers to the biological process by which endothelial cells in the intestine form a functional barrier that selectively regulates the movement of water and solutes. This process allows the creation and maintenance of compartments with distinct fluid and solute compositions, which is vital for intestinal physiology and overall organismal homeostasis.
Why Is establishment of endothelial intestinal barrier Important in Cell Biology?
The endothelial intestinal barrier is a critical regulator of intestinal and systemic homeostasis. It prevents the uncontrolled leakage of solutes and pathogens into the bloodstream, thereby limiting inflammation and maintaining immune privilege in the gut. Its dysfunction is a hallmark of several diseases, including inflammatory bowel disease and sepsis, and it influences cancer metastasis by shaping the vascular niche. Moreover, the barrier is dynamically regulated by environmental and immune signals, such as aryl hydrocarbon receptor (AHR) ligands and interferons, highlighting its integration with broader physiological networks.
• Maintains selective permeability to water and solutes, preserving compartmental differences.
• Prevents systemic inflammation by limiting microbial and endotoxin translocation.
• Regulates immune cell trafficking into the intestinal mucosa.
• Influences gut-liver axis communication and metabolic homeostasis.
• Dysfunction is linked to inflammatory bowel disease (IBD) and sepsis.
• Endothelial barrier integrity affects cancer metastasis to the liver and other organs.
• AHR signaling in endothelial cells modulates intestinal homeostasis and barrier function.
• Pericytes contribute to vascular stability and barrier maintenance in the gut.
• Microfluidic and 3D models enable precise study of barrier establishment and drug testing.
• CRISPR screening can identify novel regulators of endothelial barrier function.
What Happens During establishment of endothelial intestinal barrier?
Endothelial Cell Activation and Specification
In simple terms: Endothelial cells in the intestine receive signals that tell them to become barrier-forming cells.
The establishment of the endothelial intestinal barrier begins with the activation of endothelial cells by local cues, including growth factors and inflammatory mediators. These signals induce transcriptional programs that specify a barrier phenotype, characterized by the expression of junctional proteins and transporters. AHR signaling in endothelial cells has been shown to be crucial for intestinal homeostasis, influencing barrier integrity and immune cell interactions. Pericytes also play a supportive role in stabilizing the vascular niche and promoting barrier formation.
Formation of Intercellular Junctions
In simple terms: Endothelial cells connect tightly to each other to seal the gaps between them.
A key step in barrier establishment is the assembly of intercellular junctions, including tight junctions and adherens junctions. These junctions are composed of proteins such as claudins, occludin, and VE-cadherin, which form a physical seal that restricts paracellular transport. The integrity of these junctions is dynamically regulated by signaling pathways, including those downstream of AHR and interferon receptors. Disruption of junctional complexes leads to increased permeability and is associated with inflammatory conditions.
Regulation by Immune and Environmental Signals
In simple terms: The barrier is constantly tuned by signals from the immune system and the environment.
The endothelial intestinal barrier is not static; it is continuously modulated by immune signals such as interferons and cytokines. For example, continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier, illustrating how immune signaling can reinforce barrier function. Similarly, AHR ligands from the diet or microbiota influence endothelial barrier properties and intestinal homeostasis. These regulatory circuits ensure that the barrier adapts to physiological demands while maintaining selectivity.
Maintenance and Repair
In simple terms: The barrier must be maintained and repaired when damaged.
Once established, the endothelial intestinal barrier requires ongoing maintenance to preserve its integrity. Repair mechanisms are activated in response to injury or inflammation, involving the proliferation and migration of endothelial cells and the reformation of junctions. Pericytes contribute to vascular stability and repair in the gut. Dysregulated repair can lead to chronic barrier dysfunction, as seen in inflammatory bowel disease.
Key Genes Involved in GO:0090557 establishment of endothelial intestinal barrier
The following genes and proteins are key players in the establishment and regulation of the endothelial intestinal barrier, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AHR | Aryl hydrocarbon receptor; senses environmental ligands to regulate barrier function | Endothelial-specific knockout models show disrupted intestinal homeostasis |
| IFNAR1 | Type I interferon receptor; mediates IFNα signaling in endothelial cells | Knockout affects vascular antimetastatic barrier in liver |
| CLDN5 | Tight junction protein claudin-5; controls paracellular permeability | Target for barrier modulation in inflammation |
| OCLN | Occludin; tight junction component | Overexpression enhances barrier integrity |
| CDH5 | VE-cadherin; adherens junction protein | Essential for endothelial cell-cell adhesion |
| PDGFRB | Platelet-derived growth factor receptor beta; pericyte recruitment | Pericyte coverage supports barrier stability |
| RGS5 | Regulator of G-protein signaling 5; pericyte marker | Involved in vascular stabilization |
| NOS3 | Endothelial nitric oxide synthase; regulates vascular tone and permeability | Modulates barrier function via NO production |
| VEGFA | Vascular endothelial growth factor A; induces permeability | Overexpression increases leakiness |
| TJP1 | Zonula occludens-1; tight junction scaffold protein | Knockdown disrupts junction assembly |
| CTNNB1 | Beta-catenin; adherens junction and signaling | Regulates endothelial barrier and proliferation |
| NFKB1 | NF-kappa-B; inflammatory signaling | Activation increases permeability |
| TNF | Tumor necrosis factor; pro-inflammatory cytokine | Induces barrier disruption in IBD models |
| IL6 | Interleukin-6; cytokine | Contributes to barrier dysfunction in inflammation |
| CXCL12 | Chemokine; regulates endothelial cell migration | Influences barrier repair |
| MMP9 | Matrix metalloproteinase 9; degrades extracellular matrix | Promotes barrier breakdown during inflammation |
| TGFB1 | Transforming growth factor beta 1; modulates endothelial function | Can enhance or disrupt barrier depending on context |
How Is establishment of endothelial intestinal barrier Regulated?
The establishment and maintenance of the endothelial intestinal barrier are regulated by a complex network of signaling pathways. AHR signaling in endothelial cells is a key regulator of intestinal homeostasis, with endothelial-specific AHR deletion leading to impaired barrier function and increased susceptibility to inflammation. Interferon signaling, particularly IFNα, shapes a vascular antimetastatic barrier in the liver, demonstrating the role of immune surveillance in barrier regulation. Pericytes provide paracrine support through PDGFB-PDGFRB signaling, which stabilizes the vascular niche and promotes barrier integrity. Inflammatory cytokines such as TNF and IL-6 can disrupt barrier function by downregulating junctional proteins and increasing permeability, as observed in IBD models. Additionally, myokine-mediated muscle-organ interactions may influence endothelial barrier properties, though the mechanisms are still being elucidated.
establishment of endothelial intestinal barrier and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AHR | IBD, intestinal homeostasis | Endothelial-specific AHR knockout mice |
| IFNAR1 | Cancer metastasis, liver barrier | Hepatic endothelial IFNAR1 knockout mice |
| CLDN5 | IBD, sepsis | Cldn5 knockout or overexpression in intestinal endothelial cells |
| TNF | IBD, inflammation | TNF-induced barrier disruption in 3D IBD models |
| PDGFRB | Vascular stability, pericyte function | Pdgfrb knockout mice or pericyte co-culture |
Inflammatory Bowel Disease (IBD)
Disruption of the endothelial intestinal barrier is a hallmark of IBD, contributing to chronic inflammation and tissue damage. In a 3D multi-layered in vitro model of IBD, barrier dysfunction was associated with increased permeability and inflammatory cytokine production. The gut-liver axis is also affected, as barrier breakdown allows bacterial products to reach the liver, exacerbating inflammation. Targeting endothelial barrier restoration is a potential therapeutic strategy in IBD.
Cancer Metastasis
The endothelial barrier acts as a gatekeeper against metastatic spread. In the liver, continuous sensing of IFNα by hepatic endothelial cells establishes a vascular antimetastatic barrier that prevents tumor cell extravasation. Loss of this barrier function promotes metastasis. Understanding how endothelial cells maintain this barrier could lead to new anti-metastatic therapies.
Sepsis and Systemic Inflammation
During sepsis, systemic inflammation leads to endothelial barrier disruption in the intestine, allowing bacterial translocation and worsening the condition. The gut-liver axis plays a central role, as barrier failure in the gut can trigger liver inflammation and multi-organ dysfunction. Experimental models using microfluidic systems can help study sepsis-induced barrier changes.
From establishment of endothelial intestinal barrier-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate endothelial barrier integrity? | Endothelial-specific knockout (e.g., Cdh5-Cre; Xfl/fl) |
| Does a point mutation in gene Y affect barrier function? | Knock-in of point mutant via CRISPR |
| Can overexpression of gene Z enhance barrier? | Endothelial-specific overexpression (e.g., ROSA26-LSL-Z) |
| What is the role of a tagged protein in barrier establishment? | Tagged knock-in (e.g., GFP) for imaging |
| Which genes are essential for barrier formation? | Genome-wide CRISPR knockout library screening |
| How do immune signals modulate barrier? | Co-culture of endothelial cells with immune cells in microfluidic devices |
How to Study the establishment of endothelial intestinal barrier Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Microfluidic on-chip barrier assay | Transepithelial/endothelial electrical resistance (TEER), permeability | Real-time monitoring of barrier establishment |
| 3D multi-layered IBD model | Barrier integrity, cytokine secretion | Modeling inflammation-induced barrier disruption |
| CRISPR knockout screening | Gene essentiality for barrier function | Identification of novel regulators |
| RNA-seq | Transcriptional changes during barrier establishment | Profiling gene expression in endothelial cells |
| Proteomics | Protein expression and post-translational modifications | Quantifying junctional protein levels |
| Live-cell imaging | Junction dynamics, cell morphology | Visualizing barrier formation in real time |
| Permeability assay (FITC-dextran) | Paracellular flux | Quantifying barrier leakiness |
| Co-culture systems | Cell-cell interactions | Studying pericyte-endothelial crosstalk |
In Vitro Barrier Models
Microfluidic on-chip intestinal barrier biosystems allow real-time monitoring of barrier establishment and permeability under flow conditions. These systems can incorporate multiple cell types, including endothelial cells, epithelial cells, and immune cells, to mimic the gut microenvironment. They are valuable for studying the effects of drugs, cytokines, and genetic perturbations on barrier function.
3D Multi-layered Models
3D multi-layered in vitro models of IBD have been developed to study endothelial barrier disruption in a more physiologically relevant context. These models use hydrogels and multiple cell layers to recreate the intestinal wall, enabling the analysis of barrier integrity, cytokine release, and immune cell infiltration.
Genetic Screening
CRISPR-based knockout and activation screens can identify novel regulators of endothelial barrier function. For example, a genome-wide knockout screen in intestinal microvascular endothelial cells can reveal genes essential for barrier establishment. Such screens are complemented by transcriptomic and proteomic analyses to validate hits.
Imaging and Permeability Assays
Live-cell imaging of junctional proteins (e.g., VE-cadherin-GFP) and permeability assays using fluorescent tracers (e.g., FITC-dextran) are standard methods to assess barrier integrity. These techniques can be applied in both 2D and 3D models to quantify barrier function dynamically.
How CRISPR Can Be Used to Study GO:0090557 establishment of endothelial intestinal barrier
Knockout
CRISPR knockout of candidate genes in intestinal endothelial cells is a powerful approach to determine their role in barrier establishment. For example, endothelial-specific knockout of AHR using Cdh5-Cre and Ahrfl/fl mice demonstrated its essential role in intestinal homeostasis. In vitro, knockout of tight junction genes like CLDN5 can be achieved using CRISPR-Cas9 to study permeability changes.
Point Mutation
Point mutations can be introduced via CRISPR base editing or homology-directed repair to model specific amino acid changes in barrier-related proteins. This is useful for dissecting the function of phosphorylation sites or ligand-binding residues in receptors such as IFNAR1.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags allows visualization and purification of endothelial cells and junctional proteins. For instance, tagging VE-cadherin with GFP enables live imaging of adherens junction dynamics during barrier formation.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can be used to test whether increasing the level of a gene enhances barrier function. Overexpression of occludin or claudin-5 may strengthen the barrier and protect against inflammation.
How EDITGENE Supports establishment of endothelial intestinal barrier Research
Researchers studying establishment of endothelial intestinal barrier-related genes often need to determine whether a candidate gene is causally involved in barrier formation, maintenance, or disruption. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes identified through screening or omics studies.
Contact EDITGENE today to design your custom CRISPR model for establishment of endothelial intestinal barrier research.
Frequently Asked Questions About establishment of endothelial intestinal barrier
What is GO:0090557?
GO:0090557 is the Gene Ontology term for 'establishment of endothelial intestinal barrier', the biological process by which endothelial cells in the intestine form a selective barrier controlling water and solute passage.
What genes are involved in establishment of endothelial intestinal barrier?
Key genes include AHR, IFNAR1, CLDN5, OCLN, CDH5, and PDGFRB, among others, as identified in published studies.
Why is the endothelial intestinal barrier important?
It maintains gut homeostasis, prevents systemic inflammation, and regulates immune cell trafficking and cancer metastasis.
How is the endothelial intestinal barrier studied?
Researchers use in vitro models like microfluidic on-chip systems and 3D multi-layered cultures, combined with CRISPR screens and imaging.
What diseases are linked to endothelial intestinal barrier dysfunction?
Inflammatory bowel disease, sepsis, and cancer metastasis are associated with barrier disruption.
Can CRISPR be used to study endothelial intestinal barrier genes?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect gene function in barrier biology.
What is the role of AHR in the endothelial intestinal barrier?
AHR senses environmental ligands and regulates intestinal homeostasis, including endothelial barrier function.
How do pericytes contribute to the endothelial intestinal barrier?
Pericytes provide paracrine support and stabilize the vascular niche, promoting barrier integrity.
What are microfluidic models of the intestinal barrier?
Microfluidic on-chip systems recreate the intestinal barrier with multiple cell types and flow, allowing real-time permeability measurements.
What is the gut-liver axis?
The gut-liver axis refers to the bidirectional communication between the gut and liver, heavily dependent on intact endothelial barriers.
Conclusion
The establishment of the endothelial intestinal barrier (GO:0090557) is a vital process that safeguards intestinal and systemic health. Its dysregulation contributes to major diseases, including IBD, sepsis, and cancer. Advances in in vitro modeling and CRISPR-based gene editing are accelerating the discovery of molecular regulators and potential therapeutic targets. EDITGENE's comprehensive services support researchers in functionally validating these targets and translating findings into clinical applications.
References
- 1. Pabst O et al.. 2023. Gut-liver axis: barriers and functional circuits.. Nat Rev Gastroenterol Hepatol 20(7):447-461 PMID: 37085614
- 2. Wang H et al.. 2024. Establishment and evaluation of on-chip intestinal barrier biosystems based on microfluidic techniques.. Mater Today Bio 26:101079 PMID: 38774450
- 3. Wiggins BG et al.. 2023. Endothelial sensing of AHR ligands regulates intestinal homeostasis.. Nature 621(7980):821-829 PMID: 37586410
- 4. Liu P et al.. 2021. Establishment and characterization of a rat intestinal microvascular endothelial cell line.. Tissue Cell 72:101573 PMID: 34116500
- 5. Yi J et al.. 2025. Myokine-mediated muscle-organ interactions: Molecular mechanisms and clinical significance.. Biochem Pharmacol 242(Pt 2):117326 PMID: 40957493
- 6. Ramirez M et al.. 2019. Pericytes in the Gut.. Adv Exp Med Biol 1122:73-100 PMID: 30937864
- 7. Tran NL et al.. 2022. Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier.. Elife 11 PMID: 36281643
- 8. Ferreira B et al.. 2025. Establishment of a 3D multi-layered in vitro model of inflammatory bowel disease.. J Control Release 377:675-688 PMID: 39617170
